APIs
| Classification | API | Remark |
| Anti-Cancer | Decitabine | GMP |
| Anti-Cancer | Docetaxel | GMP,DMF |
| Anti-Cancer | Erlotinib hydrochloride | DMF |
| Anti-Cancer | Fludarabine Phosphate | USP37, GMP, DMF |
| Anti-Cancer | Gemcitabine HCL | USP37, GMP, CEP |
| Anti-Cancer | Medroxyprogesterone Acetate | GMP |
| Anti-Cancer | Palbociclib | Validation completed |
| Anti-Cancer | Paclitaxel | GMP,DMF |
| Anti-Cancer | Irinotecan | GMP DMF |
| Anti-Cancer | Sunitinib malate | Intermediates available |
| Anti-biotics | Cefotaxime sodium | GMP |
| Anti-biotics | Faropenem Sodium | GMP |
| Anti-biotics | Spectinomycin dihydrochloride | GMP |
| Anti-biotics | Pazufloxacin Mesilat | GMP |
| Anti-biotics | Vancomycin | GMP |
| Anticoagulant | Argatroban | GMP,commercial production |
| Anticoagulant | Betrixaban | Intermediates available |
| Antidepressant | Agomelatine | Commercialized |
| Antidepressant | Amisulpride | EP,commerical |
| Antidepressant | Mirtazapine | GMP,DMF |
Polypeptide
| Status | API | CAS No. |
| commercial | Atosiban Acetate | 90779-69-4 |
| commercial | Carbetocin | 37025-55-1 |
| R&D | Degarelix | 214766-78-6 |
| commercial | Desmopressin Acetate | 16789-98-3 |
| R&D | Ganirelix | 123246-29-7 |
| R&D | Liraglutide | 204656-20-2 |
| Commercial | Octreotide Acetate | 83150-76-9 |
| R&D | Semaglutide | 910463-68-2 |
| R&D | Sincalide | 25126-32-3 |
| GMP | Terlipressin Acetate | 14636-12-5 |
| Commerical | Thymalfasin | 69440-99-9 |
| R&D | Ziconotide | 107452-89-1 |